In addition, a known inhibitor of inflammation AHR (Aryl hydrocarbon receptor) (Li et al., 2011) was predicted to be inactive in NASH relative to healthy controls. The gene discussed is AHR; the disease is metabolic dysfunction-associated steatohepatitis.